Axel Janssen Mechanisms and Evolution of Colistin Resistance in Clinical Enterobacteriaceae

Total Page:16

File Type:pdf, Size:1020Kb

Axel Janssen Mechanisms and Evolution of Colistin Resistance in Clinical Enterobacteriaceae Mechanisms and evolution of colistin resistance in clinical Enterobacteriaceae Axel Janssen Mechanisms and evolution of colistin resistance in clinical Enterobacteriaceae Axel B. Janssen Mechanisms and evolution of colistin resistance in clinical Enterobacteriaceae PhD thesis, Utrecht University, Utrecht, the Netherlands Author: Axel B. Janssen Cover design: Axel B. Janssen Lay-out: Axel B. Janssen Printing: ProefschriftMaken ISBN: 978-94-6380-950-4 © Axel B. Janssen, 2020, Utrecht, the Netherlands. All rights reserved. No parts of this thesis may be reproduced, stored in a retrieval system, or transmitted in any form or by any means without prior permission of the author. The copyright of articles that have been published has been transferred to the respective journals. Printing of this thesis was financially supported by: the Netherlands Society of Medical Microbiology, the Royal Netherlands Society for Microbiology, Infection & Immunity Utrecht, and the University Medical Center Utrecht. Mechanisms and evolution of colistin resistance in clinical Enterobacteriaceae Mechanismen en evolutie van colistin resistentie in klinische Enterobacteriaceae (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof. dr. H.R.B.M. Kummeling, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op dinsdag 3 november 2020 des middags te 12.45 uur door Absalom Benjamin Janssen geboren op 31 oktober 1991 te Nijmegen Promotoren: Prof. dr. R.J.L. Willems Prof. dr. ir. W. van Schaik Beoordelingscommissie: Prof. dr. J.A.J.W. Kluytmans Prof. dr. S.H.M. Rooijakkers Prof. dr. J.W.A. Rossen Prof. dr. J.P.M. Tommassen Dr. ir. M.G.J. de Vos Paranimfen: Dr. T.P. Praest Ing. M. Salomons Table of contents Chapter 1 General introduction 8 Chapter 2 Nonclonal emergence of colistin resistance associated 34 with mutations in the BasRS two-component system in Escherichia coli bloodstream isolates Chapter 3 Microevolution of acquired colistin resistance in 66 Enterobacteriaceae isolated from ICU patients receiving selective decontamination of the digestive tract Chapter 4 Genomic characterization of colistin heteroresistance in 98 Klebsiella pneumoniae during a nosocomial outbreak Chapter 5 In vitro evolution of colistin resistance in the 124 Klebsiella pneumoniae complex follows multiple evolutionary trajectories with variable effects on fitness and virulence characteristics Chapter 6 General discussion 170 Closing Nederlandse samenvatting (Dutch summary) 188 pages Acknowledgements List of publications About the author Chapter 1 General introduction Axel B. Janssen Chapter 1 Escherichia coli and Klebsiella pneumoniae as multidrug‑resistant Gram‑negative opportunistic pathogens 1 Escherichia coli and Klebsiella pneumoniae are facultative anaerobic, rod‑shaped, Gram‑negative opportunistic pathogens in the Enterobacteriaceae family, and are asymptomatic colonizers of the intestinal microbiota (1–3). In addition, K. pneumoniae also asymptotically colonizes the skin, and the upper respiratory tract. E. coli and K. pneumoniae are frequently observed pathogens, that can cause infections outside of their respective niches. Common opportunistic infections caused by both E. coli and K. pneumoniae are bloodstream, and urinary tract infections (4–7). Individually, E. coli is well known to cause enteric infections (1, 5), whilst K. pneumoniae may also cause soft tissue infections, and pneumonia (2, 8). K. pneumoniae, together with Enterococcus faecium, Staphylococcus aureus, Acinetobacter baumannii, Pseudomonas aeruginosa, and species from the Enterobacter genus, is a member of the group of ESKAPE pathogens (9). Together, like the acronym of their genus names suggests, they are known for their ability to evade the effects of antibiotic treatments in patients, through various mechanisms of antibiotic resistance. Due to the increasing rate of antibiotic resistance, it has been suggested to include E. coli in this group; forming the ESKAPEE pathogens (10). The rate of antibiotic resistance in both E. coli and K. pneumoniae has increased all over the world, over the last two decades (11, 12). Both species have become increasingly resistant to multiple types of antibiotics, including fluoroquinolones, third‑generation cephalosporins, and aminoglycosides (5, 11, 13, 14). Through the spread of carbapenemases located on mobile genetic elements, K. pneumoniae has also increasingly acquired carbapenem resistance (5, 11, 13–16). Some countries report sporadic outbreaks of carbapenem‑resistant K. pneumoniae, but other countries suffer from endemic presence these types of resistant K. pneumoniae (5, 16). Thus, the prevalence of carbapenem resistance in K. pneumoniae varies greatly between countries. Within the European Union, the rate of carbapenem resistance in invasive K. pneumoniae isolates has been determined to vary between 0% and 64% between countries. Within carbapenem‑resistant K. pneumoniae, the rate of resistance against colistin in carbapenem‑resistant K. pneumoniae has been estimated at 28% (17). In contrast to K. pneumoniae, the rate of carbapenem resistance in invasive E. coli isolates is lower, with 0‑2% of isolates reported as resistant, depending on the individual country (13, 18). A notable point in the increasing number of infections caused by multidrug‑resistant E. coli and K. pneumoniae is the spread of particularly multidrug‑resistant lineages. Within E. coli, the ST131 lineage is known for its ability to cause extra‑intestinal infections (1). Within the ST131 lineage, the C clade 10 General introduction is particularly well‑known for its multidrug‑resistant nature, with the acquisition of CTX‑M class extended‑spectrum ß‑lactamases, making this group resistant to third‑generation cephalosporins. Furthermore, clade C ST131 E. coli strains have 1 also acquired fluoroquinolone resistance through point mutations in DNA gyrase and DNA topoisomerase genes (19, 20). Within K. pneumoniae, the ST15, ST147, ST258, and ST395 are well known multidrug‑resistant lineages. These lineages can harbour CTX‑M class extended‑spectrum ß‑lactamases, but also NDM‑type, or OXA‑48‑type carbapenemases (21–23). Some of these multidrug‑resistant E. coli and K. pneumoniae lineages are also particularly well‑equipped to cause infections through the acquisition of virulence factors on the mobile genetic elements that can encode the antibiotic resistance genes (24). The increasing rate of multidrug resistance, including carbapenem resistance in Enterobacteriaceae and other types of Gram‑negative bacteria, has led to a revival in the use of colistin as a last‑resort drug to treat infections with these opportunistic pathogens (25). In some countries, failures in hospital hygiene measures has lead an endemic spread of carbapenem‑resistant K. pneumoniae lineages. In these countries, this spread has led to an particular increase in the use of colistin in order to treat infections with these pathogens (26, 27). However, as the use of colistin has increased, outbreaks with carbapenem‑resistant, but also colistin‑resistant K. pneumoniae in clinical settings are increasingly frequent (23, 28–31). The increasing prevalence of Enterobacteriaceae that are resistant to both carbapenems, and colistin, is of growing concern for public health. Colistin: a Gram‑negative selective antibiotic Colistin belongs to the polymyxin class of antibiotics. Polymyxin antibiotics were first isolated from Paenibacillus polymyxa in 1947 and were first used in clinical settings in the 1950s (32). Polymyxins are amphipathic, non‑ribosomally synthesized, cyclic lipopeptides, composed of a decapeptide with an intramolecular heptapeptide loop, and an N‑terminal fatty acid group (Figure 1A). A number of different polymyxins have been described, varying in their exact composition of amino acids in the peptide portion, and fatty acid group (32). From the ten amino acids, those in positions 3, 6, 7, and 10 may vary. The fatty acid group may vary from a seven‑ to a nine‑carbon fatty acid, and may be methylated, hydroxylated, or sulphonated (32–34). Although there is variation in the exact composition of the each polymyxin, the amphipathic structure of polymyxins is conserved. The hydrophobic aspects of polymyxins is conserved in both the fatty acid group, and the hydrophobic 11 Chapter 1 characteristics of the variable amino acids in position 6 and 7 (Figure 1A) (32, 34). The hydrophilic nature is conserved in the polar residue of threonine at position 1 2, the cationic residues of the L‑α,γ‑diaminobutyric acid (Dab) groups in positions 1, 5, 8, and 9, and the conserved hydrophilic characteristics of the variable amino acids in positions 3 and 10 (32, 34). These hydrophobic and hydrophilic traits of the polymyxin molecule allow the molecule to fold into an amphipathic structure. This characteristic is crucial to the mechanism of action of polymyxins. Since colistin is the most widely used polymyxin, and because all polymyxins have similar characteristics, we have used colistin as a representative for the polymyxin class of antibiotics in the rest of this thesis (32, 33). Figure 1: Chemical structure of polymyxins and colistin. A) General chemical structure of polymyxins. Polymyxins are composed of a non‑ribosomally synthesized decapaptide (amino acids are number 1 through 10) with an intramolecular loop (amino acids 4 through 10), linked to a fatty acid (FA) (32). The fatty acid may differ between
Recommended publications
  • The Shiga Toxin Producing Escherichia Coli
    microorganisms Review An Overview of the Elusive Passenger in the Gastrointestinal Tract of Cattle: The Shiga Toxin Producing Escherichia coli Panagiotis Sapountzis 1,* , Audrey Segura 1,2 , Mickaël Desvaux 1 and Evelyne Forano 1 1 Université Clermont Auvergne, INRAE, UMR 0454 MEDIS, 63000 Clermont-Ferrand, France; [email protected] (A.S.); [email protected] (M.D.); [email protected] (E.F.) 2 Chr. Hansen Animal Health & Nutrition, 2970 Hørsholm, Denmark * Correspondence: [email protected] Received: 22 May 2020; Accepted: 7 June 2020; Published: 10 June 2020 Abstract: For approximately 10,000 years, cattle have been our major source of meat and dairy. However, cattle are also a major reservoir for dangerous foodborne pathogens that belong to the Shiga toxin-producing Escherichia coli (STEC) group. Even though STEC infections in humans are rare, they are often lethal, as treatment options are limited. In cattle, STEC infections are typically asymptomatic and STEC is able to survive and persist in the cattle GIT by escaping the immune defenses of the host. Interactions with members of the native gut microbiota can favor or inhibit its persistence in cattle, but research in this direction is still in its infancy. Diet, temperature and season but also industrialized animal husbandry practices have a profound effect on STEC prevalence and the native gut microbiota composition. Thus, exploring the native cattle gut microbiota in depth, its interactions with STEC and the factors that affect them could offer viable solutions against STEC carriage in cattle. Keywords: cattle; STEC colonization; microbiota; bacterial interactions 1. Introduction The domestication of cattle, approximately 10,000 years ago [1], brought a stable supply of protein to the human diet, which was instrumental for the building of our societies.
    [Show full text]
  • Extensive Microbial Diversity Within the Chicken Gut Microbiome Revealed by Metagenomics and Culture
    Extensive microbial diversity within the chicken gut microbiome revealed by metagenomics and culture Rachel Gilroy1, Anuradha Ravi1, Maria Getino2, Isabella Pursley2, Daniel L. Horton2, Nabil-Fareed Alikhan1, Dave Baker1, Karim Gharbi3, Neil Hall3,4, Mick Watson5, Evelien M. Adriaenssens1, Ebenezer Foster-Nyarko1, Sheikh Jarju6, Arss Secka7, Martin Antonio6, Aharon Oren8, Roy R. Chaudhuri9, Roberto La Ragione2, Falk Hildebrand1,3 and Mark J. Pallen1,2,4 1 Quadram Institute Bioscience, Norwich, UK 2 School of Veterinary Medicine, University of Surrey, Guildford, UK 3 Earlham Institute, Norwich Research Park, Norwich, UK 4 University of East Anglia, Norwich, UK 5 Roslin Institute, University of Edinburgh, Edinburgh, UK 6 Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Banjul, The Gambia 7 West Africa Livestock Innovation Centre, Banjul, The Gambia 8 Department of Plant and Environmental Sciences, The Alexander Silberman Institute of Life Sciences, Edmond J. Safra Campus, Hebrew University of Jerusalem, Jerusalem, Israel 9 Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK ABSTRACT Background: The chicken is the most abundant food animal in the world. However, despite its importance, the chicken gut microbiome remains largely undefined. Here, we exploit culture-independent and culture-dependent approaches to reveal extensive taxonomic diversity within this complex microbial community. Results: We performed metagenomic sequencing of fifty chicken faecal samples from Submitted 4 December 2020 two breeds and analysed these, alongside all (n = 582) relevant publicly available Accepted 22 January 2021 chicken metagenomes, to cluster over 20 million non-redundant genes and to Published 6 April 2021 construct over 5,500 metagenome-assembled bacterial genomes.
    [Show full text]
  • Molecular Characterization of Cytolethal
    Hinenoya et al. BMC Microbiology 2014, 14:97 http://www.biomedcentral.com/1471-2180/14/97 RESEARCH ARTICLE Open Access Molecular characterization of cytolethal distending toxin gene-positive Escherichia coli from healthy cattle and swine in Nara, Japan Atsushi Hinenoya1, Kensuke Shima1,5, Masahiro Asakura1, Kazuhiko Nishimura1, Teizo Tsukamoto1, Tadasuke Ooka2, Tetsuya Hayashi2, Thandavarayan Ramamurthy3, Shah M Faruque4 and Shinji Yamasaki1* Abstract Background: Cytolethal distending toxin (CDT)-producing Escherichia coli (CTEC) has been isolated from patients with gastrointestinal or urinary tract infection, and sepsis. However, the source of human infection remains unknown. In this study, we attempted to detect and isolate CTEC strains from fecal specimens of healthy farm animals and characterized them phenotypically and genotypically. Results: By PCR analysis, the cdtB gene was detected in 90 and 14 out of 102 and 45 stool specimens of healthy cattle and swine, respectively, and none from 45 chicken samples. Subtypes of the cdtB genes (I to V) were further examined by restriction fragment length polymorphism analysis of the amplicons and by type-specific PCRs for the cdt-III and cdt-V genes. Of the 90 cdtB gene-positive cattle samples, 2 cdt-I,25cdt-III,1cdt-IV,52cdt-V and 1 both cdt-III and cdt-V gene-positive strains were isolated while 1 cdt-II and 6 cdt-V gene-positive were isolated from 14 cdtB positive swine samples. Serotypes of some isolates were identical to those of human isolates. Interestingly, a cdt-II gene-positive strain isolated from swine was for the first time identified as Escherichia albertii. Phylogenetic analysis grouped 87 E.
    [Show full text]
  • Clinical Significance of Escherichia Albertii
    DISPATCHES biochemical properties (6–9). A large number of E. albertii Clinical strains might have been misidentifi ed as EPEC or EHEC Signifi cance of because they possess the eae gene. The Study Escherichia albertii We collected 278 eae-positive strains that were Tadasuke Ooka, Kazuko Seto, Kimiko Kawano, originally identifi ed by routine diagnostic protocols Hideki Kobayashi, Yoshiki Etoh, as EPEC or EHEC. They were isolated from humans, Sachiko Ichihara, Akiko Kaneko, Junko Isobe, animals, and the environment in Japan, Belgium, Brazil, Keiji Yamaguchi, Kazumi Horikawa, and Germany during 1993–2009 (Table 1; online Technical Tânia A.T. Gomes, Annick Linden, Appendix, wwwnc.cdc.gov/pdfs/11-1401-Techapp.pdf). Marjorie Bardiau, Jacques G. Mainil, To characterize the strains, we fi rst determined their Lothar Beutin, Yoshitoshi Ogura, intimin subtypes by sequencing the eae gene as described and Tetsuya Hayashi (online Technical Appendix). Of the 275 strains examined, 267 possessed 1 of the 26 known intimin subtypes (4 Discriminating Escherichia albertii from other subtypes—η, ν, τ, and a subtype unique to C. rodentium— Enterobacteriaceae is diffi cult. Systematic analyses were not found). In the remaining 8 strains, we identifi ed showed that E. albertii represents a substantial portion 5 new subtypes; each showed <95% nt sequence identity of strains currently identifi ed as eae-positive Escherichia to any known subtype, and they were tentatively named coli and includes Shiga toxin 2f–producing strains. subtypes N1–N5. For subtype N1, 3 variants were identifi ed Because E. albertii possesses the eae gene, many strains might have been misidentifi ed as enterohemorrhagic or (N1.1, N1.2, and N1.3, with >95% sequence identity among enteropathogenic E.
    [Show full text]
  • Whole Genome Sequence Typing and Analysis of Non-O157 Stec
    WHOLE GENOME SEQUENCE TYPING AND ANALYSIS OF NON-O157 STEC January 2020 1 Scottish E. coli O157/STEC Reference Laboratory Department of Laboratory Medicine Royal Infirmary of Edinburgh Little France Edinburgh EH16 4SA Tel: +44 (0)131 2426013 Main Authors: Lesley Allison, Principal Scientist, Scottish E. coli O157/STEC Reference Laboratory Anne Holmes, Clinical Scientist, Scottish E. coli O157/STEC Reference Laboratory Mary Hanson, Director, Scottish E. coli O157/STEC Reference Laboratory Contributing Author: Melissa Ward, Sir Henry Wellcome Postdoctoral Research Fellowship (WT103953MA), University of Edinburgh (E. coli O26:H11 phylogenetic analysis) 1 CONTENTS 1 Scientific and lay summaries 1.1 Scientific summary 1.2 Lay summary 1.3 Glossary 2 Introduction 2.1 Background 2.1.1 Shiga toxin-producing Escherichia coli (STEC) 2.1.2 Assessment of Pathogenicity 2.1.3 Assigning Pathogenic Potential 2.1.4 Sources of Infection 2.1.5 The Scottish E. coli O157/STEC Reference Laboratory (SERL) 2.1.6 Guidance for Screening for STEC in Scotland 2.1.7 Laboratory Diagnosis 2.1.8 Isolation of STEC 2.1.9 Strain Typing 2.1.10 Prevalence of STEC in Scotland 2.1.11 The Scottish Culture Collection 2.2 Aims of the study 3 Methods 3.1 The Study Group 3.2 DNA extraction, Library Preparation and Sequencing 3.3 Data Analysis 3.4 Phylogenomic Analysis. 3.4.1 Core genome (cg) MLST 3.4.2 Reference Based Assembly of E. coli O26:H11 4 Results 4.1 Isolates Confirmed as non-O157 E. coli by Diagnostic Laboratories 4.2 Molecular typing and Characterisation of non-O157 STEC 4.2.1 Species Identification and Serotyping 4.2.2 7-Gene MLST 4.2.3 Shiga Toxin Gene Profile 4.2.4 Virulence Gene Detection 4.2.5 Acquired Antimicrobial Resistance 4.3 Phylogenetic Overview of Non-O157 STEC 4.4 Potential to Cause Clinical Disease – JEMRA Level Assignment 4.5 Predominant, Emerging and Hybrid Strains: a comparison with published data 4.5.1 E.
    [Show full text]
  • Composition of Gut and Oropharynx Bacterial Communities in Rattus
    He et al. BMC Veterinary Research (2020) 16:413 https://doi.org/10.1186/s12917-020-02619-6 RESEARCH ARTICLE Open Access Composition of gut and oropharynx bacterial communities in Rattus norvegicus and Suncus murinus in China Wen-qiao He1†, Yi-quan Xiong1,2†, Jing Ge1,3, Yan-xia Chen1, Xue-jiao Chen1, Xue-shan Zhong1, Ze-jin Ou1, Yu-han Gao1, Ming-ji Cheng1, Yun Mo1, Yu-qi Wen1, Min Qiu1, Shu-ting Huo1, Shao-wei Chen1, Xue-yan Zheng1, Huan He1, Yong-zhi Li1, Fang-fei You1, Min-yi Zhang1 and Qing Chen1* Abstract Background: Rattus norvegicus and Suncus murinus are important reservoirs of zoonotic bacterial diseases. An understanding of the composition of gut and oropharynx bacteria in these animals is important for monitoring and preventing such diseases. We therefore examined gut and oropharynx bacterial composition in these animals in China. Results: Proteobacteria, Firmicutes and Bacteroidetes were the most abundant phyla in faecal and throat swab samples of both animals. However, the composition of the bacterial community differed significantly between sample types and animal species. Firmicutes exhibited the highest relative abundance in throat swab samples of R. norvegicus, followed by Proteobacteria and Bacteroidetes. In throat swab specimens of S. murinus, Proteobacteria was the predominant phylum, followed by Firmicutes and Bacteroidetes. Firmicutes showed the highest relative abundance in faecal specimens of R. norvegicus, followed by Bacteroidetes and Proteobacteria. Firmicutes and Proteobacteria had almost equal abundance in faecal specimens of S. murinus, with Bacteroidetes accounting for only 3.07%. The family Streptococcaceae was most common in throat swab samples of R.
    [Show full text]
  • Isolation of Human Pathogen Escherichia Albertii from Faeces of Seals (Leptonychotes Weddelli) in James Ross Island, Antarctica
    CZECH POLAR REPORTS 3 (2): 173-183, 2013 Isolation of human pathogen Escherichia albertii from faeces of seals (Leptonychotes weddelli) in James Ross Island, Antarctica Ivo Sedláček1*, Linda Grillová2, Eva Kroupová1, Jitka Černohlávková1, David Šmajs2 1Czech Collection of Microorganisms, Department of Experimental Biology, Faculty of Science, Masaryk University, Tvrdého 14, 602 00 Brno, Czech Republic 2Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, 602 00 Brno, Czech Republic Abstract A set of nine gram-negative fermenting rods biochemically identified as Escherichia coli was isolated from faeces of seals. These bacteria were characterized by phenotypic classification, 16S rDNA sequence analyses, automated ribotyping, study of whole-cell protein profiles by SDS-PAGE and finally by bacteriocin production. The results of our polyphasic taxonomic study supported the recognition of P4652, P4653 and P4740 isolates as true members of Escherichia albertii species – probably a major enteric human pathogen. To our best knowledge, this is the first evidence showing that E. albertii produces bacteriocin, colicin D. Obtained data unambiguously showed incon- venience of commercial identification systems to distinguish both Escherichia species due to missing data of E. albertii in the commercial databases. The results of Escherichia isolates taxonomy suggest seals as a novel source of human and animal pathogen, E. albertii in the Antarctic region. Key words: identification, bacteriocin, biotyping, ribotyping, SDS-PAGE The GenBank accession numbers for the 16S rRNA gene sequences of Escherichia albertii P4652 (CCM 8505) and P4653 are KF891381 and KF891382, respectively. DOI: 10.5817/CPR2013-2-18 ——— Received November 22, 2013, accepted December 12, 2013. *Corresponding author: Ivo Sedláček <[email protected]> Acknowledgements: This work was supported by the Operational Programme Education for Competitiveness project CEB (CZ.1.07/2.3.00/20.0183).
    [Show full text]
  • Diarrhoeagenic Escherichia Coli and Escherichia Albertii in Brazil: Pathotypes and Serotypes Over a 6-Year Period of Surveillanc
    Epidemiology and Infection Diarrhoeagenic Escherichia coli and Escherichia albertii in Brazil: pathotypes and serotypes over cambridge.org/hyg a 6-year period of surveillance 1 2 2 2 3 Original Paper E. L. Ori , E. H. Takagi , T. S. Andrade , B. T. Miguel , M. C. Cergole-Novella , B. E. C. Guth4, R. T. Hernandes5, R. C. B. Dias5, S. R. S. Pinheiro1, C. H. Camargo1, Cite this article: Ori EL et al (2019). 1 1 Diarrhoeagenic Escherichia coli and Escherichia E. C. Romero and L. F. Dos Santos albertii in Brazil: pathotypes and serotypes over a 6-year period of surveillance. 1Adolfo Lutz Institute-Centre of Bacteriology (National Reference Laboratory for Escherichia coli Enteric Infections), – Epidemiology and Infection 147,e10,1 9. Sao Paulo, Brazil; 2Adolfo Lutz Institute-Centre of Interdisciplinary Procedures (Culture Collections of https://doi.org/10.1017/S0950268818002595 Microorganisms), Sao Paulo, Brazil; 3Adolfo Lutz Institute-Regional Laboratory of Santo André, Sao Paulo, Brazil; 4 5 Received: 24 January 2018 Universidade Federal de São Paulo, Sao Paulo, Brazil and Universidade Estadual Paulista, Botucatu, Brazil Revised: 14 August 2018 Accepted: 20 August 2018 Abstract Key words: Diarrhoeagenic Escherichia coli (DEC) is a leading cause of infectious diarrhoea worldwide. In Bacterial infections; diarrhoea; Escherichia coli recent years, Escherichia albertii has also been implicated as a cause of human enteric diseases. (E. coli); molecular epidemiology; surveillance This study describes the occurrence of E. coli pathotypes and serotypes associated with enteric Author for correspondence: illness and haemolytic uremic syndrome (HUS) isolated in Brazil from 2011 to 2016. L. F. Dos Santos, Pathotypes isolated included enteropathogenic E.
    [Show full text]
  • Extensive Microbial Diversity Within the Chicken Gut Microbiome Revealed by Metagenomics and Culture
    This is a repository copy of Extensive microbial diversity within the chicken gut microbiome revealed by metagenomics and culture. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/173881/ Version: Published Version Article: Gilroy, R., Ravi, A., Getino, M. et al. (17 more authors) (2021) Extensive microbial diversity within the chicken gut microbiome revealed by metagenomics and culture. PeerJ, 9. e10941. ISSN 2167-8359 https://doi.org/10.7717/peerj.10941 Reuse This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the authors for the original work. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Extensive microbial diversity within the chicken gut microbiome revealed by metagenomics and culture Rachel Gilroy1, Anuradha Ravi1, Maria Getino2, Isabella Pursley2, Daniel L. Horton2, Nabil-Fareed Alikhan1, Dave Baker1, Karim Gharbi3, Neil Hall3,4, Mick Watson5, Evelien M. Adriaenssens1, Ebenezer Foster-Nyarko1, Sheikh Jarju6, Arss Secka7, Martin Antonio6, Aharon Oren8, Roy R. Chaudhuri9, Roberto La Ragione2, Falk Hildebrand1,3 and Mark J.
    [Show full text]
  • The Role of Genomic Versatility in Multi-Niche Preferences of Escherichia Coli Gitanjali Nandakafle South Dakota State University
    South Dakota State University Open PRAIRIE: Open Public Research Access Institutional Repository and Information Exchange Electronic Theses and Dissertations 2018 The Role of Genomic Versatility in Multi-Niche Preferences of Escherichia Coli Gitanjali NandaKafle South Dakota State University Follow this and additional works at: https://openprairie.sdstate.edu/etd Part of the Biology Commons, and the Microbiology Commons Recommended Citation NandaKafle, Gitanjali, "The Role of Genomic Versatility in Multi-Niche Preferences of Escherichia Coli" (2018). Electronic Theses and Dissertations. 2463. https://openprairie.sdstate.edu/etd/2463 This Dissertation - Open Access is brought to you for free and open access by Open PRAIRIE: Open Public Research Access Institutional Repository and Information Exchange. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Open PRAIRIE: Open Public Research Access Institutional Repository and Information Exchange. For more information, please contact [email protected]. THE ROLE OF GENOMIC VERSATILITY IN MULTI-NICHE PREFERENCES OF ESCHERICHIA COLI BY GITANJALI NANDAKAFLE A dissertation submitted in partial fulfillment of the requirements for the Doctor of Philosophy Major in Biological Sciences Specialization in Microbiology South Dakota State University 2018 iii ACKNOWLEDGEMENTS First and foremost, I would like to express my sincere gratitude and deep appreciation to my advisor Dr. Volker S. Brözel for his continuous support and guidance throughout my PhD study and research. I greatly appreciate the freedom he has given me to do my research and develop myself as researcher in the best possible way. I have been extremely lucky to have him as my supervisor, who cared so much about my research and, responded to my questions and queries promptly despite of his busy schedules.
    [Show full text]
  • A Review of the Taxonomy, Genetics and Biology of the Genus Escherichia and the Type Species Escherichia Coli
    Canadian Journal of Microbiology A Review of the Taxonomy, Genetics and Biology of the Genus Escherichia and the Type Species Escherichia coli Journal: Canadian Journal of Microbiology Manuscript ID cjm-2020-0508.R1 Manuscript Type: Review Date Submitted by the 13-Feb-2021 Author: Complete List of Authors: Yu, Daniel ; University of Alberta School of Public Health, Room 357 South Academic Bldg, University of Alberta Banting, Graham; University of Alberta School of Public Health, Room 357 South Academic Bldg, University of Alberta Neumann, DraftNorman; University of Alberta School of Public Health, Room 357 South Academic Bldg, University of Alberta; Keyword: Escherichia coli, taxonomy, host specificity, ecotype, genetics Is the invited manuscript for consideration in a Special Not applicable (regular submission) Issue? : © The Author(s) or their Institution(s) Page 1 of 67 Canadian Journal of Microbiology A Review of the Taxonomy, Genetics and Biology of the Genus Escherichia and the Type Species Escherichia coli Daniel Yu1, Graham Banting1, and Norman F. Neumann1* 1School of Public Health, University of Alberta, Edmonton, Alberta, Canada, T6G IC9 Draft * Corresponding Author: Dr. Norman F. Neumann Professor and Vice Dean School of Public Health Room 3-381 Edmonton Clinic Health Academy University of Alberta Edmonton, Alberta, Canada. T6G 1C9 Email: [email protected] 1 © The Author(s) or their Institution(s) Canadian Journal of Microbiology Page 2 of 67 ABSTRACT Historically, bacteriologists have relied heavily on biochemical and structural phenotypes for bacterial taxonomic classification. However, advances in comparative genomics has led to greater insights into the remarkable genetic diversity within the microbial world, and even within well-accepted species such as Escherichia coli.
    [Show full text]
  • Genomic Evidence for Revising the Escherichia Genus and Description of Escherichia
    bioRxiv preprint doi: https://doi.org/10.1101/781724; this version posted September 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Title: Genomic evidence for revising the Escherichia genus and description of Escherichia 2 ruysiae sp. nov. 3 4 Running title (51/54 characters incl. spaces): Genomic evidence for revising the Escherichia 5 genus 6 7 Boas C.L. van der Puttena,b,#, Sébastien Matamorosa, COMBAT consortium†, Constance 8 Schultsza,b 9 aAmsterdam UMC, University of Amsterdam, Department of Medical Microbiology, 10 Meibergdreef 9, Amsterdam, Netherlands 11 bAmsterdam UMC, University of Amsterdam, Department of Global Health, Amsterdam 12 Institute for Global Health and Development, Meibergdreef 9, Amsterdam, Netherlands 13 #Corresponding author, email: [email protected] 14 †Members listed in the appendix. 15 16 Abstract (223/250 words) 17 The Escherichia/Shigella genus comprises four Escherichia species, four Shigella species, and 18 five lineages currently not assigned to any species, termed ‘Escherichia cryptic clades’ 19 (numbered I, II, III, IV and VI). Correct identification of Escherichia cryptic clades is strongly bioRxiv preprint doi: https://doi.org/10.1101/781724; this version posted September 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license.
    [Show full text]